0
Patients Records Yearly
0.5 MILLION
Healthcare Professionals
0
Projects to Date

Medimix is a global technology company that specializes in providing business understanding, Real World Evidence insights and information support to the pharmaceutical, diagnostic, and medical device industries. Our solutions leverage big data and evidence based information, to advise and support business decisions in forecasting, marketing, commercial analytics, business intelligence, health economics, medical affairs, strategy and licensing.

500,000 

Patients Records Yearly

2.5 MILLION 

Healthcare Professionals

2,000 

Projects to Date

Medimix is a global technology company that specializes in providing business understanding, Real World Evidence insights and information support to the pharmaceutical, diagnostic, and medical device industries. Our solutions leverage big data and evidence based information, to advise and support business decisions in forecasting, marketing, commercial analytics, business intelligence, health economics, medical affairs, strategy and licensing.

LiveTracker

Continuous tracker
Strategic KPIs
Real time ATU
Tx Sequencing

Monitor Launch in real time

IdeaCloud

Open Innovation
crowd sourcing platform

Discover and Implement Innovative Ideas

ScanBuzz

Healthcare Social Media monitoring platform

Gather unbiased customer insights

Allocator

Sales Force effectiveness operational audit platforms

Increase the ROI of your salesforce

Montevideo, Uruguay (Back office)

Sao Paolo, Brazil (LatAm HQ)

Shanghai, China (Biz Dev)

Bacolod, Philippines (Back Office)

Hong Kong (Asian HQ)

Miami (Global HQ)

London, United Kingdom (EU HQ)

Basel, Switzerland (Biz Dev)

Paris, France (Biz Dev)

Boston, MA (Biz Dev)

Jersey City, NJ (Biz Dev)

San Francisco, CA (Biz Dev)

Tokyo, Japan

The crucial importance of Real World Evidence

Health-care is an essential factor in human lives. Every hospital, pharmaceutical industry, health care professionals and all other medical related components are constantly looking to [...]

NSCLC Treatment Paradigm: Where Do We Stand?

NSCLC Treatment Paradigm: Where Do We Stand?   NSCLC treatment paradigm: where do we stand? Lung cancer is, by a large margin, the leading cause [...]

  • MEDIMIX International on AML Hematology Tracker

Recent AML Launches – What Have We Learned?

Recent Launches for Acute Myeloid Leukemia (AML) What We’ve Learned Advancements in medicine have equipped physicians to assign distinct prognostic groups to patients with AML [...]

Social Media
Medimix Banner Separator

Follow us on